alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
<PAGE>

                                                                    Exhibit 99.1

                            CERTIFICATION PURSUANT TO
                           18 U.S.C. SECTION 1350, AS
                         ADOPTED PURSUANT TO SECTION 906
                        OF THE SARBANES-OXLEY ACT OF 2002

         In connection with the Annual Report on Form 10-K of AmericanWest
Bancorporation (the "Company") for the period ending December 31, 2002 as filed
on the date hereof (the "Report"), I, Wesley E. Colley, President and Chief
Executive Officer, hereby certify, pursuant to 18 U.S.C. Section 1350, as
adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to the
best of my knowledge:

         1.    The Report fully complies with the requirements of section 13(a)
or 15(d) of the Securities Exchange Act of 1934; and

         2.    The information contained in the Report fairly presents, in all
material respects, the financial condition and result of operations of the
Company.

         Dated:  March 26, 2003.

                                         /s/ Wesley E. Colley
                                         ---------------------------------------
                                         Wesley E. Colley
                                         President and Chief Executive Officer

         In connection with the Annual Report on Form 10-K of AmericanWest
Bancorporation (the "Company") for the period ending December 31, 2002 as filed
on the date hereof (the "Report"), I, C. Tim Cassels, Vice President and Chief
Financial Officer, hereby certify, pursuant to 18 U.S.C. Section 1350, as
adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to the
best of my knowledge:

         1.    The Report fully complies with the requirements of section 13(a)
or 15(d) of the Securities Exchange Act of 1934; and

         2.    The information contained in the Report fairly presents, in all
material respects, the financial condition and result of operations of the
Company.

         Dated:  March 26, 2003.

                                         /s/ C. Tim Cassels
                                         ---------------------------------------
                                         C. Tim Cassels
                                         Vice President and Chief Financial
                                         Officer
Exhibit
      32.1






CERTIFICATION
      PURSUANT TO






18
      U.S.C.
      SECTION 1350,






AS
      ADOPTED PURSUANT TO






SECTION
      906 OF THE SARBANES-OXLEY ACT OF 2002






In
      connection with the Annual Report of B2Digital, Incorporated, (the "Company")
      on
      Form 10-KSB for the period ended March 31, 2007, as filed with the Securities
      and Exchange Commission on the date hereof (the "Report"), I, Robert Russell,
      Chief Executive Officer and Marcia Pearlstein, Interim Chief Financial Officer,
      of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant
      to Section 906 of the Sarbanes-Oxley Act of 2002, that:






(1)
      The
      Report fully complies with the requirements of Section 13(a) or 15(d) of the
      Securities Exchange Act of 1934; and






(2)
      The
      information contained in the Report fairly presents, in all material respects,
      the financial condition and results of operations of the Company.








*/s/
              Robert Russell*Robert
              RussellChief
              Executive Officer





***/s/
              Marcia Pearlstein*Marcia
                PearlsteinInterim
              Chief Financial Officer






*Dated:
      July 16 , 2007*
Exhibit 31.1 Certification pursuant to 18 U.S.C. Section 1350 as adopted pursuant to Section 302 of theSarbanes-Oxley Act of 2002 and pursuant to Rule 13a-14(a) and Rule 15d-14 under the SecuritiesExchange Act of 1934In connection with the Quarterly Report Pursuant to Section 13 or 15(d) of the SecuritiesExchange Act of 1934 on Form 10-QSB of Gulf Coast Oil & Gas, Inc. (the “Company”) for the periodended June 30, 2005, as filed with the Securities and Exchange Commission on the date hereof (the“Report”), I, Rahim Rayani, CEO of the Company, certify, pursuant to 18 U.S.C. Sec.1350, as adoptedpursuant to Section 302 and 906 of the Sarbanes-Oxley Act of 2002, and pursuant to Rule 13a-14under the Securities Exchange Act of 1934, that:1. I have reviewed the Report being filed;2. Based on my knowledge, the Report does not contain any untrue statement of a material factor omit to state a material fact necessary to make the statements made, in light of thecircumstances under which such statements were made, not misleading with respect to the periodcovered by the Report;3. Based on my knowledge, the financial statements, and other financial information includedin the Report, fairly present in all material respects the financial condition, results ofoperations and cash flows of the Company as of, and for, the period presented in the Report;4. I am responsible for establishing and maintaining disclosure controls and procedures (assuch term is defined in paragraph (c) of Rule 13a-14) for the Company and have:     i. Designed such disclosure controls and procedures to ensure that material informationrelating to the Company, including its consolidated subsidiaries, if any, is made known to them byothers within those entities, particularly during the period in which the periodic reports arebeing prepared;     ii. Evaluated the effectiveness of the Company’s disclosure controls and procedures as ofa date within 90 days prior to the filing date of the Report (“Evaluation Date”); and     iii. Presented in the Report their conclusions about the effectiveness of the disclosurecontrols and procedures based on their evaluation as of the Evaluation Date;5. I have disclosed, based on my most recent evaluation, to the Company’s auditors and theaudit committee of the board of directors (or persons fulfilling the equivalent function):     i. All significant deficiencies in the design or operation of internal controls whichcould adversely affect the Company’s ability to record, process, summarize and report financialdata and have identified for the Company’s auditors any material weaknesses in internal controls;and     ii. Any fraud, whether or not material, that involves management or other employees whohave a significant role in the Company’s internal controls; and6. I have indicated in the report whether or not there were significant changes in internalcontrols or in other factors that could significantly affect internal controls subsequent to thedate of their most recent evaluation, including any corrective actions with regard to significantdeficiencies and material weaknesses.   Dated: August 20, 2005    /s/ Rahim Rayani     Rahim Rayani, CEO
I 

112TH CONGRESS 

1ST SESSION H. R. 1316 

To direct the Commissioner of Food and Drugs to modify the approval 

of any drug containing controlled-release oxycodone hydrochloride to limit 

such approval to use for the relief of severe-only instead of moderateto-severe pain, and for other purposes. 

IN THE HOUSE OF REPRESENTATIVES 

APRIL 1, 2011 

Mrs. BONO MACK (for herself, Mr. ROGERS of Kentucky, Mr. LYNCH, Mr. 

WOLF, Mr. BUCHANAN, and Mr. MACK) introduced the following bill; 

which was referred to the Committee on Energy and Commerce 

A BILL 

To direct the Commissioner of Food and Drugs to modify 

the approval of any drug containing controlled-release 

oxycodone hydrochloride to limit such approval to use 

for the relief of severe-only instead of moderate-to-severe 

pain, and for other purposes. 

1 Be it enacted by the Senate and House of Representa2 tives of the United States of America in Congress assembled, 

3 SECTION 1. SHORT TITLE. 

4 This Act may be cited as the ‘‘Stop Oxy Abuse Act 

5 of 2011’’. 


jbell on DSKDVH8Z91PROD with BILLS
2 

•HR 1316 IH

1 SEC. 2. LIMITING APPROVAL OF DRUGS CONTAINING CON2 TROLLED-RELEASE OXYCODONE HYDRO3 CHLORIDE TO USE FOR RELIEF OF SEVERE4 ONLY PAIN. 

5 (a) IN GENERAL.—Not later than 90 days after the 

6 date of the enactment of this Act, the Commissioner of 

7 Food and Drugs shall take such actions as may be nec8 essary— 

9 (1) to modify the approval of any drug con10 taining controlled-release oxycodone hydrochloride 

11 under section 505 of the Federal Food, Drug, and 

12 Cosmetic Act (21 U.S.C. 355) to limit such approval 

13 to use for the relief of severe-only instead of mod14 erate-to-severe pain; and 

15 (2) to limit any subsequent approval of a drug 

16 containing controlled-release oxycodone hydro17 chloride under such section to use for the relief of 

18 severe-only pain. 

19 (b) APPLICABILITY.—Any modification required by 

20 subsection (a)(1) shall apply to drugs introduced or deliv21 ered for introduction into interstate commerce on or after 

22 the date that is 180 days after the date of the enactment 

23 of this Act. 

Æ 


jbell on DSKDVH8Z91PROD with BILLS
## United States Court of Appeals FOR THE EIGHTH CIRCUIT

___________ No. 06-2968

___________ Vincent Hussey, * * Appellant, * * v. * Appeal from the United States * District Court for the * Eastern District of Arkansas. Marvin Evans, Warden, Maximum * Security Unit, ADC; Max Mobley, * Deputy/Assistant Director, Arkansas * [UNPUBLISHED] Department of Correction; Sangoseni, * Dr., Arkansas Department of * Correction; Charlotte Green, * Infirmary Administrator, Maximum * Security Unit, ADC, originally * Sued as “C. Green”; Jonathan E. * Simmons, Dr., Arkansas Department * of Correction, originally sued as * “Simmons”; Tommy James, Asst. * Warden, Maximum Security Unit, * ADC (originally sued as James); * Ophelia Grandy, Infirmary Manager, * Maximum Security Unit, ADC, * originally sued as “O. Grandy”; * John Byus, Director of Medical Care, * Arkansas Department of Correction, * * Appellees. *1 The Honorable William R. Wilson, Jr., United States District Judge for the Eastern District of Arkansas, adopting the report and recommendations of the Honorable Jerry W. Cavaneau, United States Magistrate Judge for the Eastern District of Arkansas.

2 The Honorable Jerry W. Cavaneau, United States Magistrate Judge for the Eastern District of Arkansas, to whom the case was referred for final disposition by consent of the parties pursuant to 28 U.S.C. § 636(c).

3 We decline to address the allegations Hu ssey raises for the first time on appeal. See Naucke v. City of Park Hills , 284 F.3d 923, 927 n.2 (8th Cir. 2002).
-2- ___________ Submitted: July 13, 2007 Filed: July 19, 2007

___________ Before MURPHY, SMITH, and SHEPHERD, Circuit Judges.

___________ PER CURIAM. Arkansas inmate Vincent Hussey appeals the district court’s 1 orders granting summary judgment to one defendant, and dismissing without prejudice another defendant for failure to serve pr ocess; and the district court’s 2subsequent adverse grant of summary judgment to the remaini ng defendants. Having carefully reviewed the record, we affirm. See Johnson v. Blaukat , 453 F.3d 1108, 1112 (8th Cir. 2006) (summary judgment standard of review); Lee v. Armontrout , 991 F.2d 487, 489 (8th Cir. 1993) (per curiam) (it is in forma pauperis plaintiff’s responsibility to provide proper address for service). 3
Accordingly, we affirm. See 8th Cir. R. 47B.

______________________________
EXHIBIT 32.1


                  CERTIFICATION PURSUANT TO RULE 13a-14(b) and
                             18 U.S.C. SECTION 1350,
                             AS ADOPTED PURSUANT TO
                 Section 906 of the Sarbanes-Oxley Act of 2002


     In  connection  with the filing by Wincroft,  Inc.  (the  "Company") of the
Annual  Report  on Form  10-KSB  for the  period  ending  March  31,  2004  (the
"Report"), I, Danny Wettreich,  Chief Executive Officer of the Company, certify,
pursuant  to 18  U.S.C.  1350,  as  adopted  pursuant  to  Section  906  of  the
Sarbanes-Oxley Act of 2002, that:

          1.   The Report fully complies with the  requirements of Section 13(a)
               and 15(d) of the Securities Exchange Act of 1934; and

          2.   The information  contained in the Report fairly presents,  in all
               material  respects,   the  financial  condition  and  results  of
               operation of the Company.







                                               /s/ Danny Wettreich
                                               ---------------------------------
                                               Danny Wettreich
                                               Chief Executive Officer


Dated:  June 22, 2004
<Page>

32.1    Certification of the Chief Executive Officer and Chief Financial Officer
        of Apogee Robotics, Inc. pursuant to Section 906 of the Sarbanes Oxley
        Act of 2002


                            CERTIFICATION PURSUANT TO
                             18 U.S.C. SECTION 1350
                             AS ADOPTED PURSUANT TO
                  SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Annual Report on Form 10-KSB of Apogee Robotics, Inc.
(the "Company") for the year ended June 30, 1999 as filed with the Securities
and Exchange Commission on the date hereof (the "Report"), the undersigned
Michael Anthony, Chief Executive Officer and Chief Financial Officer of Apogee
Robotics, Inc., certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant
to Section 906 of the Sarbanes-Oxley Act of 2002, that:

(1) the Report fully complies with the requirements of Section 13(a) or 15(d) of
the Securities Exchange Act of 1934; and

(2) the information contained in the Report fairly presents, in all material
respects, the financial condition and results of operations of the Company.

Dated: August 28, 2007

                                                      /s/ Michael Anthony
                                                      ----------------------
                                                      Michael Anthony
                                                      Chief Executive Officer

                                                      /s/ Michael Anthony
                                                      ----------------------
                                                      Michael Anthony
                                                      Chief Financial Officer
NOT FINAL UNTIL TIME EXPIRES TO FILE REHEARING

MOTION AND, IF FILED, DETERMINED

IN THE DISTRICT COURT OF APPEAL

OF FLORIDA

SECOND DISTRICT

ADAM P. DOOLEY, DOC #T03310, )

)

Appellant, )

)

v. ) Case No. 2D17-2089

)

STATE OF FLORIDA, )

)

Appellee. )

)

Opinion filed March 21, 2018.

Appeal from the Circuit Court for 

Hillsborough County; Michelle Sisco, 

Judge.

Adam P. Dooley, pro se.

Pamela Jo Bondi, Attorney General, 

Tallahassee and Jonathan P. Hurley, 

Assistant Attorney General, Tampa, for 

Appellee.

PER CURIAM.

Affirmed. 

KELLY, LUCAS, and BADALAMENTI, JJ., Concur.
**Exhibit 32.1**

 

PUBLICMEDIA WORKS, INC.

 

CERTIFICATIONPURSUANT TO18 U.S.C. §1350,AS ADOPTED PURSUANT TOSECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

 

In connection with theQuarterly Report of Public Media Works, Inc. (the “Company”) on Form 10-QSB forthe period ending May 31, 2004, as filed with the Securities and ExchangeCommission on the date hereof (the “Report”), I, Thomas A. Szabo, ChiefExecutive Officer and Chairman of the Company, certify, pursuant to 18 U.S.C.§1350, as adopted pursuant to §906 of the Sarbanes-Oxley Act of 2002, that:

 

(1)                                  The Report fullycomplies with the requirements of section 13(a) or 15(d) of the SecuritiesExchange Act of 1934; and

 

(2)                                  The information contained in the Reportfairly presents, in all material respects, the financial condition and resultsof operations of the Company.

 

 
| Date:  July 19, 2004 | /s/ Thomas A. Szabo                   |   |
|--------------------------------|---------------------------------------|--------|
|                           | Thomas A. Szabo                       |
|                           | Chief Executive Officer  and Chairman |

 

A signed original of thiswritten statement required by Section 906 has been provided to the Companyand will be retained by the Company and furnished to the Securities andExchange Commission or its staff upon request.

 

----
```

[Congressional Bills 104th Congress]
[From the U.S. Government Publishing Office]
[S. 532 Engrossed in Senate (ES)]

  1st Session
                                 S. 532

_______________________________________________________________________

                                 AN ACT

 
     To clarify the rules governing venue, and for other purposes.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. VENUE.

    Paragraph (3) of section 1391(a) of title 28, United States Code, 
is amended by striking ``the defendants are'' and inserting ``any 
defendant is''.

            Passed the Senate March 30 (legislative day, March 27), 
      1995.

            Attest:

                                                             Secretary.
104th CONGRESS

  1st Session

                                 S. 532

_______________________________________________________________________

                                 AN ACT

     To clarify the rules governing venue, and for other purposes.
```
Exhibit 32



CERTIFICATION PURSUANT TO 
18 U.S.C. SECTION 1350, 
AS ADOPTED PURSUANT TO 
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002



In connection with the Quarterly Report of Communicate.com Inc. (the Company) on Form 10-QSB for the period ending March 31, 2007 as filed with the Securities and Exchange Commission on the date hereof (the Report), I, David M. Jeffs, President, Chief Executive Officer of the Company and the sole member of the Board of Directors, certify, pursuant to s.906 of the Sarbanes-Oxley Act of 2002, that:

(1) The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2) The information contained in the Report fairly represents, the financial condition and result of operations of the Company.



/s/ David M. JeffsDavid M. Jeffs 
Chief Executive Officer 
May 10, 2007





CERTIFICATION PURSUANT TO 
18 U.S.C. SECTION 1350, 
AS ADOPTED PURSUANT TO 
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002



In connection with the Quarterly Report of Communicate.com Inc. (the Company) on Form 10-QSB for the period ending March 31, 2007 as filed with the Securities and Exchange Commission on the date hereof (the Report), I, J. Cameron Pan, Secretary, Treasurer, and Chief Financial Officer of the Company, certify, pursuant to s.906 of the Sarbanes-Oxley Act of 2002, that:

(1) The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2) The information contained in the Report fairly represents, the financial condition and result of operations of the Company.



/s/ J. Cameron PanJ. Cameron Pan 
Chief Financial Officer 
May 10, 2007
```

[Congressional Bills 112th Congress]
[From the U.S. Government Publishing Office]
[H.R. 1432 Introduced in House (IH)]

112th CONGRESS
  1st Session
                                H. R. 1432

  To require formal rulemaking procedures for rules related to health 
                              care reform.

_______________________________________________________________________

                    IN THE HOUSE OF REPRESENTATIVES

                             April 7, 2011

  Mr. Schweikert (for himself and Mr. Paul) introduced the following 
       bill; which was referred to the Committee on the Judiciary

_______________________________________________________________________

                                 A BILL

 
  To require formal rulemaking procedures for rules related to health 
                              care reform.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. SHORT TITLE.

    This Act may be cited as the ``Creating Sunshine, Participation, 
and Accountability for our Nation Act''.

SEC. 2. FORMAL RULEMAKING REQUIREMENT.

    (a) In General.--Any rule issued under a health care reform law 
shall be made on the record after opportunity for an agency hearing.
    (b) Hearing Requirements.--The agency hearing referred to in 
subsection (a) shall be--
            (1) open to the public, including to radio and television 
        coverage; and
            (2) presided over by an officer confirmed by the Senate.
    (c) Definition.--In this Act, the term ``health care reform law'' 
means--
            (1) the Patient Protection and Affordable Care Act (Public 
        Law 111-148) and the amendments made by that Act; and
            (2) title I or subtitle B of title II of the Health Care 
        and Education Reconciliation Act of 2010 (Public Law 111-152) 
        and the amendments made by that Act.
                                 <all>
```
Document Headings

                    Document headings vary by document type but may contain                    the following:                  
                -                       the agency or agencies that issued and signed a document                    
                -                       the number of the CFR title and the number of each part                      the document amends, proposes to amend, or is directly                      related to                    
                -                       the agency docket number / agency internal file number                    
                -                       the RIN which identifies each regulatory action listed in                      the Unified Agenda of Federal Regulatory and Deregulatory                      Actions                    

                    See the                                          Document Drafting Handbook                                        for more details.                  

###### Department of Health and Human Services

###### National Institutes of Health

Pursuant to section 1009 of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meeting.

The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.

*Name of Committee:*                         National Institute of Allergy and Infectious Diseases Special Emphasis Panel; Investigator Initiated Extended Clinical Trial (R01 Clinical Trial Required).                    

*Date:*                         March 8, 2024.                    

*Time:*                         12:00 p.m. to 4:00 p.m.                    

*Agenda:*                         To review and evaluate grant applications.                    

*Place:*                         National Institute of Allergy and Infectious Diseases, National Institutes of Health, 5601 Fishers Lane, Rockville, MD 20892 (Video Assisted Meeting).                    

*Contact Person:*                         Lindsey M. Pujanandez, Ph.D., Scientific Review Officer, Immunology Review Branch, Scientific Review Program, Division of Extramural Activities, National Institute of Allergy and Infectious Diseases, National Institutes of Health, 5601 Fishers Lane, MSC 9834, Rockville, MD 20852, (240) 627-3206,                         *lindsey.pujanandez@nih.gov.*

(Catalogue of Federal Domestic Assistance Program Nos. 93.855, Allergy, Immunology, and Transplantation Research; 93.856, Microbiology and Infectious Diseases Research, National Institutes of Health, HHS)

Dated: February 6, 2024.

Lauren A. Fleck, 

Program Analyst, Office of Federal Advisory Committee Policy.

[FR Doc. 2024-02773 Filed 2-9-24; 8:45 am]

BILLING CODE 4140-01-P